Streetbeat News

Stock Prices

AUGX

Augmedix (NASDAQ:AUGX) is set to release its latest quarterly earnings report on Monday, 2023-08-07. Analysts estimate an earnings per share (EPS) of $-0.13. The company's past performance shows a mixed impact on the share price post-earnings release. Shares of Augmedix were trading at $4.21 as of August 03, with a 170.0% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 8:02 pm

ALTO

Alto Ingredients (NASDAQ:ALTO) is set to release its latest quarterly earnings report on Monday, 2023-08-07. Analysts estimate an earnings per share (EPS) of $-0.07. The company's past performance shows a pattern of share price changes following earnings reports. The stock was trading at $3.87 as of August 03, with a 52-week decrease of 18.05%.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 8:02 pm

TIVC

Tivic Health Systems, Inc. (NASDAQ:TIVC) has announced its intention to offer and sell shares of its common stock in a public offering. The proceeds from the offering will be used for working capital and general corporate purposes. The completion of the offering is subject to market and other conditions.

Portfolio Pulse from Happy Mohamed

August 04, 2023 | 8:02 pm

MNKD

MannKind (NASDAQ:MNKD) is set to release its latest quarterly earnings report on Monday, 2023-08-07. Analysts estimate an earnings per share (EPS) of $-0.04. The company's past performance shows a trend of beating EPS estimates, which has led to increases in share price. Shares of MannKind were trading at $4.7 as of August 03, with an 8.28% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 8:01 pm

HNRG

Hallador Energy (NASDAQ:HNRG) is set to release its latest quarterly earnings report on August 7, 2023. Analysts estimate an earnings per share (EPS) of $0.31. The company's past performance shows a trend of beating EPS estimates, which has often led to an increase in share price. The stock is currently trading at $9.24 and has seen a 50.16% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 8:01 pm

INMB

INmune Bio (NASDAQ:INMB) is set to release its latest quarterly earnings report on August 7, 2023. Analysts estimate an earnings per share (EPS) of $-0.40. The company's past performance shows a pattern of EPS misses followed by share price increases. Shares are currently trading at $8.62, down 15.35% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 8:01 pm

PLX

Protalix BioTherapeutics (AMEX:PLX) is set to release its latest quarterly earnings report on August 7, 2023. Analysts estimate an earnings per share (EPS) of $-0.04. The company's past performance shows a mixed trend of beating and missing EPS estimates. The stock price, currently at $1.72, has seen a 51.62% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 8:01 pm

XGN

Exagen (NASDAQ:XGN) is set to release its latest quarterly earnings report on August 7, 2023. Analysts estimate an earnings per share (EPS) of $-0.48. The company's past performance shows a pattern of share price changes following earnings reports. Shares of Exagen were trading at $2.46 as of August 3, with a 59.51% decrease over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 8:01 pm

UFCS

United Fire Gr (NASDAQ:UFCS) is set to release its latest quarterly earnings report on August 7, 2023. Analysts estimate an EPS of $0.29. The company's past performance shows a trend of missing EPS estimates and subsequent share price drops. The stock is currently trading at $21.11, down 26.3% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 8:01 pm

TRHC

Tabula Rasa HealthCare (NASDAQ:TRHC) is set to release its latest quarterly earnings report on August 7, 2023. Analysts estimate an earnings per share (EPS) of $-0.14. The company's past performance shows a trend of beating EPS estimates, which has generally led to an increase in share price. The stock is currently trading at $7.88 and has seen a 52.03% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 8:01 pm